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everywhere, as it has done across 
Europe. Even in France, which 
competes with Ireland for the title of 
the EU’s most fertile member state,  
the total fertility rate dropped below 
reproduction level last year. Other 
European countries, including 
Germany, are most worried about how 
to raise it to get closer to a steady 
state and save the provisions for the 
elderly from collapse. 
The threat of an exponential 
‘explosion’ of world population 
appears to have subsided. New 
demographic challenges have replaced 
it, from the age distribution and gender 
balance through to migration between 
countries and also within countries. 
For instance, the rapid growth of 
China’s economy has depended on 
an unprecedented migration of around 
200 million people from rural areas to 
the cities, as Xin Meng explains in a 
recent book review (Science (2014) 
343, 138–139). The next challenge 
for governments in China, India, and 
other populous countries is now to 
fine-tune the development and mobility 
of their populations in ways that are 
both sustainable and acceptable to the 
people. 
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web 
page at www.michaelgross.co.uk
China’s dream: In economic terms, China 
has been spectacularly successful in the last 
decades, but will demographic challenges 
end its rise? (Photo: Stephen Codrington.)Carl Hirschie 
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What turned you on to biology in the 
first place? Music led me to science. 
When I started college, I didn’t know 
what I wanted to ‘be when I grew up’. 
Frankly, I wasn’t very excited about 
going to college in general, but I 
enrolled at the University of Texas (UT 
Austin) in an honors liberal arts program 
(called Plan II) that introduced me to an 
intellectual group of people (mostly in 
the humanities, but some scientists as 
well). I discovered rapidly that college 
was NOT merely a continuation of high 
school and that I loved the intellectual 
environment. However, ‘liberal arts’ 
wasn’t an attractive career aspiration. 
I’ve always liked challenges and since 
everyone else seemed to want to be a 
physician and it was one of the most 
competitive majors, I declared as a pre-
med along with the liberal arts major.
However, in my first year at UT, I took 
a music appreciation course and fell 
in love with classical music. I attended 
every concert that I could get into and 
became enamored with the idea of 
becoming the conductor of a major 
symphony orchestra (it remains a fond 
pipe dream!). I began piano and violin 
classes, as well as theory courses for 
the music majors. However, I had never 
had music lessons as a child and it 
was too late for me at the age of 19 to 
develop the ‘ear’. Alas! An unfulfilled 
dream.
Q & ANevertheless, it was music that 
led me to science. I’ve always had a 
passable singing voice and since I had 
never learned any other instrument, 
developing voice as my ‘instrument’ 
was the only logical course of action. 
However, voice lessons cost money 
and my widow mother was barely able 
to afford my tuition/fees/food. There 
was nothing left over for something 
as frivolous as voice lessons. So, I 
needed to get a job to earn money for 
voice lessons. There was a biology 
professor whose class I had enjoyed 
in my freshman year and I went to ask 
that professor for a job. His name is 
Michael Menaker (now a professor 
at the University of Virginia) and he 
was the first person who had a really 
profound impact on my decision to 
become a scientist. When I asked him 
for a job, he looked at me sideways (he 
knew who I was because I had asked 
a lot of questions in class) and said, 
“Yeah . . . I’ve got a job for you” and he 
put me to work in the lab. That began a 
working relationship with Dr. Menaker 
that would last the remainder of my 
undergraduate career.
I earned the money to take voice 
lessons, but more importantly I learned 
that I liked scientific research. I’ve 
always felt that research was like 
playing a chess game against nature. 
I resonate with a quote from Sir Peter 
Medawar that “the art of research 
is that of making (an apparently 
intractable) problem soluble by finding 
out (experimental) ways of getting 
at it — soft underbellies and the 
like”. Despite gravitating to research, 
however, I wasn’t very successful at 
it as an undergraduate (or for most 
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would have reacted to this lack of 
success by fleeing, but I just dug in 
stronger. I was ultimately accepted 
into medical schools and graduate 
schools, and I think the main reason 
that I finally decided to go to graduate 
school was because my undergraduate 
research project didn’t work. If it had 
worked, I probably would have felt a 
sense of closure and could have gone 
on to medical school. But because 
my project had not worked, I went to 
graduate school to finish it off. 
Who were your mentors? My 
undergraduate research in 
Dr. Menaker’s laboratory concerned 
the biological ‘clocks’ that time us 
and most other organisms. I became 
fascinated by these timekeepers, also 
called circadian (daily) rhythms, and 
that experience with Menaker inspired 
me to become a chronobiologist. 
Consequently, I went to Stanford 
University as a graduate student 
to study with the ‘head honcho’ (at 
that time) of chronobiology, Dr. Colin 
Pittendrigh (member of the National 
Academy). ‘Pitt’ (as everyone called 
him) was one of the smartest scientists 
that I’ve had the pleasure of knowing; 
he defined many of the key questions in 
chronobiology that I (and the rest of the 
field) are still characterizing.
After graduate school, I went to 
Harvard University for postdoctoral 
studies with another major figure in the 
chronobiology field, Dr. J.W. ‘Woody’ 
Hastings (member of the National 
Academy). Hastings’ claim to fame has 
been the study of bioluminescence 
in bacteria and algae. In some 
dinoflagellate algae, bioluminescence 
exhibits a circadian rhythm and 
therefore provides a rhythmically 
glowing ‘read-out’ of the endogenous 
biological clock. It has been a great 
system to study the biochemical 
control by which the central biological 
clock controls an observable rhythmic 
output (in this case, bioluminescence). 
In our later work on cyanobacteria, 
we used the same principle and 
instrumentation for monitoring rhythms, 
except that we genetically engineered 
the cyanobacteria to be rhythmically 
bioluminescent (cyanobacteria are 
not normally bioluminescent). I had a 
blast in Hastings’ lab. I loved Boston 
and I loved working on bioluminescent 
microbial organisms. Hastings and 
I established an excellent working 
relationship and friendship that continues to this day. His approach to 
operating a lab was very laissez faire; 
he provided an excellent environment 
without much direction and certainly 
without looking over the shoulders of 
his personnel. People in Hastings’ lab 
either flowered or foundered from the 
absence of direction. I blossomed. 
How do you view failures? I have failed 
more frequently than I have succeeded. 
My survival as an active scientist 
is largely due to the persistence 
mentioned above, and my mantra has 
been: as long as I keep moving, failures 
become turning points. In my case, 
one failure that became a turning point 
was the aforementioned experience 
as an undergraduate researcher that 
led me to graduate school rather than 
medical school. Another case was 
during graduate school, when I almost 
gave up due to lack of progress, but 
then reoriented my research area with 
the final result of obtaining my PhD. 
Finally, my postdoctoral research 
went well, but as a new Assistant 
Professor at Vanderbilt University, 
I again faced a watershed. The 
dinoflagellate alga that I had researched 
in Hastings’ lab was captivating, but 
I recognized that its lack of genetics 
was a major handicap in the age of 
molecular genetics. I therefore began 
to develop the genetically tractable 
alga Chlamydomonas as a model 
system for circadian studies. While I 
made progress with Chlamydomonas 
clocks, undoubtedly the most 
significant aspect of working on 
Chlamydomonas circadian rhythms 
was that it provided a segue to the 
next phase of my professional career. 
I met and established a collaboration 
with Dr. Takao Kondo (Nagoya 
University, Japan), who also worked on 
Chlamydomonas chronobiology. We 
joined forces collaboratively; I worked 
with him in Japan in 1986 and in 1994 
and he spent a sabbatical in my lab 
in 1990–91. During his sabbatical, 
we investigated the possibility of 
other model systems for the study of 
circadian rhythms and hence began 
the cyanobacterial project that has 
principally defined my career. The 
collaboration with Kondo was a 
wonderful chapter in my life. I learned to 
love Japan and its people/culture, and I 
formed a strong friendship with Kondo. 
Do you have any scientific heroes, 
dead or alive? Other than my mentors, 
at least two other scientific heroes spring to my mind. One is Charles 
Darwin, not only for his imaginative 
insight into natural selection (a concept 
independently derived by Alfred 
Russel Wallace), but also as a wide-
ranging biologist/thinker and author of 
delightful books, of which my favorites 
are The Formation of Vegetable Mould 
Through the Action of Worms with 
Observations of Their Habits (a treatise 
on earthworms) and The Voyage of 
the Beagle (the journal of his world-
altering adventure as a young man). A 
less well-known (at least, as a scientist) 
hero of mine is Alexander Borodin, 
a Russian chemist and composer of 
the 19th century. Despite important 
contributions to aldehyde chemistry, 
he is now best known for his musical 
compositions and being one of a group 
of Russian composers called ‘The Five’. 
I admire Borodin for his ability to make 
lasting contributions to both science 
and music. Another interesting fact 
about Borodin is that he was a 19th 
century feminist in Russia; he strongly 
supported female emancipation in 
general and women as physicians in 
particular. For example, Borodin was 
one of the founders of the School of 
Medicine for Women in St. Petersburg. 
Do you feel under undue pressure to 
demonstrate the potential relevance 
of your research for medicine or other 
‘applications’? I have two reactions 
to the issue of ‘relevance’. On the 
one hand, it is discouraging that the 
kind of fascinating basic research 
that inspired me to go to graduate 
school instead of medical school 
has become extraordinarily difficult 
to fund (there are some exceptional 
scientists who keep it going, such as 
my colleague at Vanderbilt, Dr. Ken 
Catania). On the other hand, taxpayers 
deserve to know what they’re paying 
for, and understandably they tend to 
think that much basic research is a 
waste of their money. One reflection 
of this is the relative funding of the 
NSF vs. the NIH in the USA. My 
field — chronobiology — has ramified 
from basic biological interest to many 
areas of medicine and health, and 
this transformation has undoubtedly 
helped it to survive and prosper. For 
me personally, I am diversifying our 
unabashedly basic research program 
towards including more applied studies 
(in humans and mice); at this stage 
of my career, I’d like at least some of 
my work to be directly pertinent to 
the health and well-being of people. 
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Precision genome 
engineering
Dana Carroll
What is precision genome 
engineering? Exactly that! You know 
what a genome is; ‘engineering’ 
means that we want to change that 
DNA, and ‘precision’ means we want 
to do it in a very specific, targeted 
way.
Sounds challenging, why would you 
want to do that? Lots of reasons. For 
example, we might want to make a 
mutation in a gene in an experimental 
organism in order to see what the 
effect was and thus get an insight 
into the gene’s function. With real 
precision, we could introduce an 
exact mutation that corresponds to a 
human genetic disease allele into an 
experimental organism. That would 
allow us to examine the physiological 
consequences of that mutation in 
more detail than we could just by 
looking at people.
Are there some more practical, 
real-world applications? You bet! 
People are using precision genome 
engineering with crop plants and 
food animals to give them improved 
characteristics. Think about maize 
that was more drought resistant, or 
canola that produced more beneficial 
oil. How about pigs with more muscle 
mass — call that pork — or dairy cows 
with no horns to bother their sisters 
or the farmer. These modifications are 
already under way.
How can you get these changes 
to be made efficiently and with 
real specificity? The key is to use 
proteins that will cut DNA — called 
nucleases — and to direct them to 
exactly the place in the genome 
that you want to modify. The first 
engineered proteins of this kind were 
called zinc-finger nucleases, or ZFNs. 
They have a nuclease attached to 
zinc finger modules that come from 
natural DNA binding proteins (mainly 
transcription factors) and know how 
to find and bind to very specific DNA 
sequences. There are natural and 
synthetic fingers that in the right 
Quick guide combination can recognize quite a range of DNA sequences. About four 
years ago, another type of DNA-
binding module was characterized 
that has a very simple way of 
recognizing DNA — one module 
for each base pair. The nucleases 
made from these are called TALENs 
(transcription activator-like effector 
nucleases), and they have stolen 
quite a bit of territory from ZFNs.
So these proteins make a cut in the 
DNA strand, but what happens then? 
Once a break is made at a specific 
site by the nuclease, the cell’s double 
strand repair machinery hurries to fix 
it and sometimes makes a mistake. 
This introduces a mutation right at 
the break site, and often knocks out 
the function of a gene. Another type 
of repair uses a DNA template to 
copy information across the break. 
If we put into cells a template that 
carries sequence changes we want to 
introduce, they will often get copied 
in. That’s how you would put in a 
human disease mutation, for example. 
Together ZFNs and TALENs have 
been used successfully to modify 
the genomes of about 30 different 
species, including humans.
Humans? You’re messing with 
my genome? No (not yet, but stay 
vigilant). Lots of genome engineering 
has been done in cultured human 
cells, partly to make disease models, 
partly just to work out the technology. 
Ultimately we want to use these 
nucleases for beneficial gene therapy. 
Right now there are clinical trials 
going on with ZFNs targeted to the 
human CCR5 gene. The product of 
this gene is a protein that the human 
immunodeficiency virus (HIV) needs 
in order to infect T cells. It turns 
out we can get along without this 
protein — there are natural CCR5 
mutants. The therapy is to take 
T cells from HIV-infected people, 
treat them in the lab to knock out 
CCR5, then put them back into the 
same person. This will prevent the 
development of AIDS by providing 
a population of HIV-resistant T 
cells, and there won’t be a rejection 
problem because the cells came from 
the same person who receives them.
Sounds amazing, but what can you 
do besides help AIDS patients? The 
things that look easiest right now are 
ones where the nuclease treatment More broadly, however, we need to get 
the message to the ordinary taxpayer 
and to legislators of the importance of 
basic research and of stable, long-
term funding for research that only 
governments can afford to support. 
I wonder if we could convince Fox 
News in the USA to have a ‘redneck 
scientist’ segment in which a ‘salt of 
the earth’ scientist explains to the Fox 
audience how basic research helps 
them individually.
You mentioned that music led you 
to science. Do you see any parallels 
between these two spheres? Music 
continues to be important to me. I sing 
with the Nashville Symphony Chorus, 
and the rehearsals and performances 
of the classical choral repertoire are 
a regular series of oases in my life. 
On the one hand, I am just 1 out of 
145 voices and am never recognized 
individually. On the other hand, it is 
a privilege and pleasure for me to 
have the opportunity to be a part of a 
program with professional musicians 
(they are totally out of my league). My 
choral participation is a metaphor for 
the way I view my ultimate contribution 
to science. There are few scientists 
who achieve name recognition status, 
and almost all of those who do reach 
that stature during their research-active 
years are practically forgotten within 
a few years after their retirement. For 
example, I have been shocked that the 
work and contributions of my graduate 
supervisor (Pittendrigh) — a dominant 
figure of chronobiology who died 17 
years ago — are rarely discussed 
nowadays. Therefore, lasting personal 
recognition is not a realistic motivation 
for becoming a researcher/teacher. 
However, we contribute to a process 
that is larger than ourselves. In that 
sense, we are each a ‘voice in the 
chorus’. While I was initially attracted 
to science by the fallacy that I might 
be recognized as having accomplished 
great things, now my goals are more 
realistic: firstly, in my teaching, I can 
influence the lives and decisions of 
hundreds of students every year in 
ways that will be largely unknowable to 
me and, secondly, in my research, I can 
enjoy an endeavor that remains fresh 
and challenging as new experimental 
results force us to continuously re-
evaluate previous conclusions.
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